Fluorine in PDB 4ty9: An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline
Protein crystallography data
The structure of An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline, PDB code: 4ty9
was solved by
W.Shui,
C.Yang,
J.Lin,
X.Chen,
S.Qin,
S.Chen,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.79 /
2.78
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
101.774,
101.643,
251.582,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
20.8 /
27.3
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline
(pdb code 4ty9). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the
An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline, PDB code: 4ty9:
Jump to Fluorine binding site number:
1;
2;
3;
Fluorine binding site 1 out
of 3 in 4ty9
Go back to
Fluorine Binding Sites List in 4ty9
Fluorine binding site 1 out
of 3 in the An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:80.2
occ:1.00
|
F01
|
A:3B0601
|
0.0
|
80.2
|
1.0
|
C04
|
A:3B0601
|
1.3
|
83.6
|
1.0
|
F
|
A:3B0601
|
2.1
|
88.5
|
1.0
|
F02
|
A:3B0601
|
2.2
|
77.8
|
1.0
|
C02
|
A:3B0601
|
2.3
|
82.7
|
1.0
|
OE1
|
A:GLU481
|
2.6
|
32.2
|
1.0
|
C03
|
A:3B0601
|
2.8
|
82.0
|
1.0
|
CB
|
A:GLU481
|
3.2
|
33.4
|
1.0
|
CA
|
A:GLU481
|
3.3
|
33.7
|
1.0
|
CD
|
A:GLU481
|
3.4
|
33.9
|
1.0
|
C05
|
A:3B0601
|
3.5
|
80.1
|
1.0
|
N
|
A:GLU481
|
3.5
|
31.6
|
1.0
|
NH2
|
A:ARG484
|
3.6
|
33.5
|
1.0
|
CG
|
A:GLU481
|
3.8
|
34.4
|
1.0
|
CZ
|
A:ARG484
|
4.1
|
34.0
|
1.0
|
ND2
|
A:ASN369
|
4.1
|
27.6
|
1.0
|
C01
|
A:3B0601
|
4.2
|
82.0
|
1.0
|
CB
|
A:SER371
|
4.2
|
29.8
|
1.0
|
C
|
A:GLY480
|
4.2
|
32.8
|
1.0
|
OG
|
A:SER478
|
4.3
|
35.4
|
1.0
|
CG2
|
A:THR385
|
4.3
|
23.5
|
1.0
|
OG
|
A:SER371
|
4.4
|
30.6
|
1.0
|
OE2
|
A:GLU481
|
4.4
|
37.6
|
1.0
|
NE
|
A:ARG484
|
4.4
|
35.8
|
1.0
|
O
|
A:GLY480
|
4.6
|
31.2
|
1.0
|
N01
|
A:3B0601
|
4.6
|
79.2
|
1.0
|
NH1
|
A:ARG484
|
4.7
|
33.3
|
1.0
|
C
|
A:GLU481
|
4.7
|
35.5
|
1.0
|
C
|
A:3B0601
|
4.9
|
81.8
|
1.0
|
OD1
|
A:ASN369
|
4.9
|
24.6
|
1.0
|
CG
|
A:ASN369
|
5.0
|
25.7
|
1.0
|
|
Fluorine binding site 2 out
of 3 in 4ty9
Go back to
Fluorine Binding Sites List in 4ty9
Fluorine binding site 2 out
of 3 in the An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:77.8
occ:1.00
|
F02
|
A:3B0601
|
0.0
|
77.8
|
1.0
|
C04
|
A:3B0601
|
1.3
|
83.6
|
1.0
|
F01
|
A:3B0601
|
2.2
|
80.2
|
1.0
|
F
|
A:3B0601
|
2.2
|
88.5
|
1.0
|
C02
|
A:3B0601
|
2.3
|
82.7
|
1.0
|
C05
|
A:3B0601
|
2.6
|
80.1
|
1.0
|
CB
|
A:SER371
|
3.1
|
29.8
|
1.0
|
OE1
|
A:GLU361
|
3.2
|
44.2
|
1.0
|
OG
|
A:SER371
|
3.2
|
30.6
|
1.0
|
OG
|
A:SER478
|
3.4
|
35.4
|
1.0
|
C03
|
A:3B0601
|
3.6
|
82.0
|
1.0
|
CA
|
A:SER371
|
3.9
|
29.0
|
1.0
|
N01
|
A:3B0601
|
4.0
|
79.2
|
1.0
|
CB
|
A:GLU481
|
4.1
|
33.4
|
1.0
|
ND2
|
A:ASN369
|
4.2
|
27.6
|
1.0
|
CB
|
A:SER478
|
4.2
|
33.8
|
1.0
|
CD
|
A:GLU361
|
4.2
|
39.9
|
1.0
|
N
|
A:GLU481
|
4.3
|
31.6
|
1.0
|
O
|
A:VAL370
|
4.4
|
24.7
|
1.0
|
CA
|
A:GLU481
|
4.6
|
33.7
|
1.0
|
OE1
|
A:GLU481
|
4.6
|
32.2
|
1.0
|
C01
|
A:3B0601
|
4.7
|
82.0
|
1.0
|
C
|
A:3B0601
|
4.8
|
81.8
|
1.0
|
CB
|
A:GLU361
|
4.8
|
30.2
|
1.0
|
N
|
A:SER371
|
4.8
|
29.1
|
1.0
|
CG
|
A:GLU361
|
4.9
|
33.8
|
1.0
|
C
|
A:VAL370
|
5.0
|
26.9
|
1.0
|
|
Fluorine binding site 3 out
of 3 in 4ty9
Go back to
Fluorine Binding Sites List in 4ty9
Fluorine binding site 3 out
of 3 in the An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of An Ligand-Observed Mass Spectrometry-Based Approach Integrated Into the Fragment Based Lead Discovery Pipeline within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:88.5
occ:1.00
|
F
|
A:3B0601
|
0.0
|
88.5
|
1.0
|
C04
|
A:3B0601
|
1.3
|
83.6
|
1.0
|
F01
|
A:3B0601
|
2.1
|
80.2
|
1.0
|
F02
|
A:3B0601
|
2.2
|
77.8
|
1.0
|
ND2
|
A:ASN369
|
2.3
|
27.6
|
1.0
|
C02
|
A:3B0601
|
2.3
|
82.7
|
1.0
|
C03
|
A:3B0601
|
2.9
|
82.0
|
1.0
|
C05
|
A:3B0601
|
3.3
|
80.1
|
1.0
|
CG
|
A:ASN369
|
3.3
|
25.7
|
1.0
|
OD1
|
A:ASN369
|
3.7
|
24.6
|
1.0
|
O
|
A:GLU361
|
3.9
|
27.6
|
1.0
|
NH2
|
A:ARG484
|
3.9
|
33.5
|
1.0
|
O
|
A:VAL370
|
3.9
|
24.7
|
1.0
|
CB
|
A:SER371
|
4.0
|
29.8
|
1.0
|
C01
|
A:3B0601
|
4.2
|
82.0
|
1.0
|
OE1
|
A:GLU481
|
4.2
|
32.2
|
1.0
|
CG2
|
A:THR385
|
4.3
|
23.5
|
1.0
|
CZ
|
A:ARG484
|
4.4
|
34.0
|
1.0
|
N01
|
A:3B0601
|
4.5
|
79.2
|
1.0
|
NH1
|
A:ARG484
|
4.5
|
33.3
|
1.0
|
CB
|
A:ASN369
|
4.6
|
25.3
|
1.0
|
OE1
|
A:GLU361
|
4.6
|
44.2
|
1.0
|
C
|
A:VAL370
|
4.6
|
26.9
|
1.0
|
CA
|
A:SER371
|
4.7
|
29.0
|
1.0
|
OG
|
A:SER371
|
4.7
|
30.6
|
1.0
|
C
|
A:3B0601
|
4.8
|
81.8
|
1.0
|
C
|
A:GLU361
|
4.9
|
25.3
|
1.0
|
CB
|
A:GLU361
|
4.9
|
30.2
|
1.0
|
N
|
A:SER371
|
4.9
|
29.1
|
1.0
|
O
|
A:ASN369
|
5.0
|
29.6
|
1.0
|
|
Reference:
X.Chen,
S.Qin,
S.Chen,
J.Li,
L.Li,
Z.Wang,
Q.Wang,
J.Lin,
C.Yang,
W.Shui.
A Ligand-Observed Mass Spectrometry Approach Integrated Into the Fragment Based Lead Discovery Pipeline Sci Rep V. 5 8361 2015.
ISSN: ESSN 2045-2322
PubMed: 25666181
DOI: 10.1038/SREP08361
Page generated: Thu Aug 1 05:45:20 2024
|